Abstract:Cideb, a member of CIDE family proteins, has emerged as an important regulator in the development of obesity and diabetes by controlling fatty acid synthesis and VLDL secretion in hepatocytes. Here, we investigated the role of Cideb in cholesterol biosynthesis, uptake and storage in the liver by using Cideb-null mice as a model system. Cideb-null mice and wild-type mice were treated with normal diet (ND) or high cholesterol diet (HCD) for one month. The metabolic parameters of cholesterol metabolism and expression profiles of genes in cholesterol biosynthesis and storage were measured. Cideb-null mice had lower levels of plasma cholesterol and LDL when fed with both ND and HCD and increased rate of cholesterol absorption. Furthermore, the liver of Cideb-null mice has lower rates of cholesterol biosynthesis and reduced expression levels of sterol response element-binding protein (SREBP) cleavage-activation protein (SCAP), and lower levels of nuclear form of SREBP2 and its downstream target genes in cholesterol biosynthesis pathway under a normal diet treatment. On the contrary, hepatic cholesterol biosynthesis rate between wild-type and Cideb-null mice was similar after high cholesterol diet treatment. Interestingly, hepatic cholesterol storage in the liver of Cideb-null mice was significantly increased due to its increased LDL receptor (LDLR) and acyl-CoA cholesterol acyltransferase (ACAT) expression. Finally, we observed drastically reduced cholesterol levels in the heart of Cideb-null mice fed with a high cholesterol diet. Overall, our data suggest that Cideb is a novel regulator in controlling cholesterol homeostasis in the liver. Therefore, Cideb could serve as an important therapeutical target for the treatment of atherosclerosis and cardiovascular diseases.

CIDE Proteins and Metabolic Disorders

C CIDE proteins and metabolic dis orders

CIDE Proteins and Lipid Metabolism.

CIDE proteins and their regulatory mechanisms in lipid droplet fusion and growth

Control of Lipid Droplet Fusion and Growth by CIDE Family Proteins

Cide Proteins and the Development of Obesity

Cideb Regulates Diet-Induced Obesity, Liver Steatosis, and Insulin Sensitivity by Controlling Lipogenesis and Fatty Acid Oxidation

Differential Roles of Cell Death-inducing DNA Fragmentation Factor-α-like Effector (CIDE) Proteins in Promoting Lipid Droplet Fusion and Growth in Subpopulations of Hepatocytes

Relationship between the Cell Death-Inducing DNA Fragmentation Factor 45-Like Effector Protein Family and the Risk of Dyslipidemia

Cidea controls lipid droplet fusion and lipid storage in brown and white adipose tissue

Coordination among Lipid Droplets, Peroxisomes, and Mitochondria Regulates Energy Expenditure Through the CIDE-ATGL-PPARα Pathway in Adipocytes.

Regulation of Cidea protein stability by the ubiquitin-mediated proteasomal degradation pathway

Downregulation of AMP-activated Protein Kinase by Cidea-mediated Ubiquitination and Degradation in Brown Adipose Tissue.

Cidea Promotes Hepatic Steatosis by Sensing Dietary Fatty Acids

Control of Cholesterol Biosynthesis, Uptake and Storage in Hepatocytes by Cideb.

Opposing roles of cell death-inducing DFF45-like effector B and perilipin 2 in controlling hepatic VLDL lipidation

Cidea-deficient Mice Have Lean Phenotype and Are Resistant to Obesity.

CIDE-A, a novel link between brown adipose tissue and obesity.

Cell death-inducing DNA fragmentation factor A-like effector A and fat-specific protein 27β coordinately control lipid droplet size in brown adipocytes

Regulation of Lipogenesis by Cyclin-Dependent Kinase 8-Mediated Control of SREBP-1.

Cideb Facilitates the Lipidation of Chylomicrons in the Small Intestine.